
Elegen and Nutcracker Launch Cell-Free RNA Manufacturing for Personalized Cancer Therapies
Elegen and Nutcracker Therapeutics Launch Cell‑Free Platform for Personalized Cancer RNA Therapies Pilot program introduces the first fully synthetic, cell‑free process to streamline manufacturing of RNA-based personalized cancer therapeutics (PCTs) Elegen, a pioneer in next‑generation DNA manufacturing, and Nutcracker Therapeutics,…